// App-Quantinova.ai

: Safety of Peanut (Arachis Hypogaea) Allergen Powder-dnfp in Children and Teenagers With Peanut Allergy: Pooled Analysis From Controlled and Open-Label Phase 3 Trials

Researchers

Presenter

  • Thomas Casale

Principal Investigators

  • A. Wesley Burks

  • James Baker

  • Jonathan OB Hourihane

  • Kirsten Beyer

  • Brian Vickery

  • Stacie Jones

  • George Du Toit

  • J. Andrew Bird

  • Alex Smith

  • Kari Brown

  • Stephen Tilles

Medical Centers

  • University of North Carolina Food Allergy Initiative, Division of Allergy, Immunology and Rheumatology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

  • Mary H Weiser Food Allergy Center, University of Michigan, Ann Arbor, MI, USA

  • Paediatrics and Child Health, Royal College of Surgeons in Ireland, Dublin, Ireland

  • Charite Univsmedizin Berlin, Berlin, Germany

  • University of Arkansas for Medical Sciences and Arkansas Children's Hospital Research Institute, Little Rock, AR

  • Guy's And St Thomas NHS Foundation Trust, London, United Kingdom

  • Department of Pediatrics, Division of Allergy and Immunology, University of Texas Southwestern Medical Center, Dallas, TX, USA

  • Aimmune Therapeutics, Brisbane, CA, USA

Locations

  • United States

  • Ireland

  • Germany

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Open Label

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved